公开(公告)号：US20240009137A1

公开(公告)日：2024-01-11

申请号：US18254983

申请日：2021-11-30

Applicant: ROYAL MELBOURNE INSTITUTE OF TECHNOLOGY

Inventor： Charlotte Elizabeth CONN ,  Jamie STRACHAN

IPC: A61K9/50 ,  A61K38/28

CPC classification number: A61K9/5084 ,  A61K38/28 ,  A61K9/5015

Abstract: A dosage form for oral delivery of a therapeutic agent to a subject, the dosage form comprising: (i) a lipid nanocarrier formulation, the lipid nanocarrier formulation comprising the therapeutic agent, and lipids in the form of a mesophase; and (ii) an enteric coating encapsulating the lipid nanocarrier formulation.